Statins and Alzheimer

By Alexander Dunn,2014-11-30 04:32
9 views 0
that future epidemiological studies and clinical trials uniformly apply an agreed-on set of biomarkers in serum and cerebrospinal fluid, particularly amyloid beta42, tau, and phospho-tau levels; that they employ brain imaging, including amyloid imaging by positron-emission tomography; and that they use cognitive measures such as the cognitive subscale of the AD Assessment Scale and, preferably, more sophisticated and specific tests of verbal and episodic memory.

Report this document

For any questions or suggestions please email